¹æ±¤¿ä°ü ¿ª·ù¿¡¼ ¿ä°üÇÏ Polydimethylsiloxane ÁÖÀÔ¼úÀÇ Ãʱâ°æÇè°ú ±â¼úÀû Ãø¸é
The Early Experience and Technical Aspects of Endoscopic Subureteral Polydimethylsiloxane Injection for Vesicoureteral Reflux
±èÇöö, ½É°¼ö, ¹®µÎ°Ç,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇöö ( Kim Hyun-Chul )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
½É°¼ö ( Shim Kang-Soo )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
¹®µÎ°Ç ( Moon Du-Geon )
°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358320060470020154
Abstract
Purpose: We reviewed the operative outcome and the cause of failure for performing subureteral injection of polydimethylsiloxane(PDS, Macroplastique , Uroplasty Inc. Geleen, The Netherlands), when it is used as a bulking agent for the endoscopic treatment of vesicoureteral reflux(VUR) patients.
Materials and Methods: A total of 29 patients (a total of 37 ureters), with primary grades I to V VUR were treated with a single subureteral injection from 2001 to 2004; these patients were followed for an average of 21.5 months. Each patient underwent preoperative voiding cystourethrography, renal ultrasound, a dimercapto-succinic acid(DMSA) scan and urine culture. With the patient under general anesthesia, the PDS implant was injected transurethrally at the 6 o¡¯clock position of the ureteral opening in the affected renal unit by a modified subureteral transurethral injection (STING) procedure. Renal ultrasound was done at 1 week and voiding cystourethrography was done at 3 months to rule out obstruction at the injection site and/or persistent reflux, respectively. Cure was defined as an absence of VUR on voiding cystourethrography at 3 months after injection. Statistical analyses were performed using the chi-square test.
Results: The grade of reflux was I, II, III, IV and V in 6, 4, 12, 9 and 6 ureteral units respectively. After a single injection, the VUR was cured in 30 ureteral units(81.1%). There were 7(18.9%) patients who received a second injection after a failed single injection. In these patients, the injected PDS volume was not changed on ultrasound. On the other hand, cystoscopy showed mound displacement in 4 patients, no volcano appearance but rather a broad elevation in 2 patient, and distal ureteral fistula and mound extrusion in 1 patient.
Conclusions: These results suggest that endoscopic subureteral polydimethylsiloxane injection is an effective treatment of VUR. The efficacy of subureteral injection can be improved by using the correct injection technique. (Korean J Urol 2006;47:154-159)
Å°¿öµå
Vesicoureteral reflux;Polydimethylsiloxane;Injections
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸